Immutep Limited Profile

0.04
USD 0.00  0.00%
66%
0%

Immutep Limited Summary

Immutep Limited (PRRUF) is traded on OTC Market in USA. It is located in 95 Pitt Street and employs 31 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 56.02 M. Immutep Limited has 2.08 B outstanding shares. PRIMA RESOURCES N has accumulated about 10.52 M in cash with (6.79 M) of positive cash flow from operations.
Check Immutep Limited Probability Of Bankruptcy

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 78.79%30 days 0.04  about 21.16%
Based on normal probability distribution, the odds of Immutep Limited to move above current price in 30 days from now is about 21.16% (This Immutep Limited probability density function shows the probability of Immutep Limited Stock to fall within a particular range of prices over 30 days) .

Immutep Limited Risk Profiles

Key Fundamentals

Immutep Limited Against Markets

Current Ratings

Immutep Limited 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
9 
Chance of
Financial Distress (0 to 100%)
< 57% 
Equity ratings for Immutep Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Immutep Limited engages in the research, development, and commercialization of medical biotechnology products in Australia. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited is traded on OTC Market in USA. more
NameImmutep Limited
CEOMarc VoigtView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address95 Pitt Street
ExchangeOTC Market
BenchmarkDOW
Websitewww.primabiomed.com.au
Contact Number61 2 8315 7003
CurrencyUSD - US Dollar

Diversify with Immutep Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Immutep Limited to your portfolio

Management

Immutep Limited Corporate Management
Larisa Chisholm Bus. Devel. and Intellectual Property Manager
Tom Bloomfield Joint Company Secretary
Frederic Triebel Chief Scientific Officer & Chief Medical Officer
Deanne Miller General Counsel, Company Secretary
Additionally take a look at Your Equity Center. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.